# Treatment Targets for Chronic Hypertension in Pregnancy

> **NCT00194974** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Weill Medical College of Cornell University**

## Conditions studied

- Pregnancy Toxemia
- Hypertension
- Proteinuria

## Interventions

- **DRUG:** methyldopa
- **DRUG:** labetalol
- **DRUG:** nifedipine
- **DRUG:** clonidine

## Key facts

- **NCT ID:** NCT00194974
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2004-07
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2017-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00194974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00194974, "Treatment Targets for Chronic Hypertension in Pregnancy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00194974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*